Lloyd Park, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Lloyd Park, LLC
- $81 Million
- Q3 2022
A detailed history of Lloyd Park, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Lloyd Park, LLC holds 3,000 shares of ALNY stock, worth $730,590. This represents 0.74% of its overall portfolio holdings.
Number of Shares
3,000
Previous 3,000
-0.0%
Holding current value
$730,590
Previous $438,000
36.99%
% of portfolio
0.74%
Previous 0.46%
Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
670Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.04 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.1 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.33 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.7 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.07 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...